Signal Transduction
Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed to Pseudomonas aeruginosa*

https://doi.org/10.1074/jbc.M109.098566Get rights and content
Under a Creative Commons license
open access

In cystic fibrosis (CF), the absence of functional cystic fibrosis transmembrane conductance regulator (CFTR) translates into chronic bacterial infection, excessive inflammation, tissue damage, impaired lung function and eventual death. Understanding the mechanisms underlying this vicious circle of inflammation is important to design better therapies for CF. We found in CF lung biopsies increased immunoreactivity for p38 MAPK activity markers. Moreover, when compared with their non-CF counterpart, airway epithelial cells expressing the most common mutation in CF (CFTRΔF508) were more potent at inducing neutrophil chemotaxis through increased interleukin (IL)-6 synthesis when challenged with Pseudomonas aeruginosa diffusible material. We then discovered that in CFTRΔF508 cells, the p38 and ERK MAPKs are hyperactivated in response to P. aeruginosa diffusible material, leading to increased IL-6 mRNA expression and stability. Moreover, although TLR5 contributes to p38 MAPK activation upon P. aeruginosa challenge, it only played a weak role in IL-6 synthesis. Instead, we found that the production of reactive oxygen species is essential for IL-6 synthesis in response to P. aeruginosa diffusible material. Finally, we uncovered that in CFTRΔF508 cells, the extracellular glutathione levels are decreased, leading to a greater sensitivity to reactive oxygen species, providing an explanation for the hyperactivation of the p38 and ERK MAPKs and increased IL-6 synthesis. Taken together, our study has characterized a mechanism whereby the CFTRΔF508 mutation in airway epithelial cells contributes to increase inflammation of the airways.

Cystic Fibrosis
Inflammation
MAP Kinases (MAPKs)
Reactive Oxygen Species (ROS)
Toll-like Receptors (TLRs)

Cited by (0)

*

This work was supported by a Canadian Cystic Fibrosis Foundation research grant (to S. R.); the Department of Medicine, McGill University; the McGill University Health Centre Research Institute (MUHC-RI); and the Canadian Foundation for Innovation-leaders opportunities funds. The Meakins-Christie Laboratories, MUHC-RI, are supported by a Centre grant from Les Fonds de la Recherche en Santé du Québec (FRSQ).

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1–3.

1

Both authors contributed equally to this work.

2

Recipient of a postdoctoral fellowship from the FRSQ.